Detalhe da pesquisa
1.
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Circulation
; 147(4): 284-295, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335517
2.
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage.
Am J Physiol Heart Circ Physiol
; 326(5): H1159-H1176, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426865
3.
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease.
Am J Physiol Heart Circ Physiol
; 326(3): H670-H688, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133623
4.
Acute Infarcts on Brain MRI Following Aortic Arch Repair With Circulatory Arrest: Insights From the ACE CardioLink-3 Randomized Trial.
Stroke
; 54(1): 67-77, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315249
5.
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling.
Am J Physiol Heart Circ Physiol
; 325(5): H1210-H1222, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773589
6.
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin.
Cardiovasc Diabetol
; 22(1): 152, 2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380983
7.
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical data.
Curr Opin Cardiol
; 38(6): 539-545, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792556
8.
Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial.
BMC Cardiovasc Disord
; 23(1): 557, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964221
9.
Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The CAMRA CardioLink-2 Study.
Circulation
; 142(14): 1342-1350, 2020 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33017212
10.
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes.
Cardiovasc Diabetol
; 20(1): 200, 2021 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607574
11.
Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?
Rev Endocr Metab Disord
; 22(4): 1171-1188, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228302
12.
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
Curr Opin Cardiol
; 36(5): 672-681, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173772
13.
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Circulation
; 140(21): 1693-1702, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434508
14.
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.
Biochem Biophys Res Commun
; 524(1): 50-56, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980166
15.
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro.
Mol Cell Biochem
; 459(1-2): 121-130, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127491
16.
A Patient-Level Pooled Analysis of 2 Empagliflozin Trials of Left Ventricular Remodeling.
J Card Fail
; 29(8): 1218-1221, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286032
17.
Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-associated aortic remodeling.
J Vasc Surg
; 68(3): 859-871, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29273297
18.
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
Diabetes Obes Metab
; 25(9): 2765-2769, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246798
19.
Cardiovascular inflammation is reduced with methotrexate in diabetes.
Mol Cell Biochem
; 432(1-2): 159-167, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303409
20.
Endothelial long non-coding RNAs regulated by oxidized LDL.
Mol Cell Biochem
; 431(1-2): 139-149, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28316063